You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trilaciclib dihydrochloride/Cosela

Showing 1 - 25 of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Los Alamitos, California
  • +6 more
Jan 25, 2023

Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

Not yet recruiting
  • Breast Neoplasms
  • Guangzhou, Gangdong, China
    Sun-yat sen university cancer center
Jul 30, 2023

Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

Not yet recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Aug 31, 2023

Metastatic NSCLC, NSCLC, Lung Cancer Trial in United States (Trilaciclib, Placebo, Docetaxel)

Terminated
  • Metastatic Non-Small Cell Lung Cancer
  • +2 more
  • Phoenix, Arizona
  • +11 more
Feb 11, 2022

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Birmingham, Alabama
  • +111 more
Oct 25, 2022

Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • Nanjing, Jiangsu, China
    The Affiliated Hospital of Nanjing University Medical School
Nov 21, 2023

Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)

Not yet recruiting
  • Breast Neoplasm
  • (no location specified)
May 8, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Advanced NSCLC Trial (Trilaciclib+Envafolimab+Docetaxel, Envafolimab+Docetaxel, Docetaxel)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jun 16, 2023

Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)

Not yet recruiting
  • Advanced Squamous Non-Small-Cell Lung Cancer
  • (no location specified)
Jun 11, 2023

Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity Trial in Worldwide (Trilaciclib, Placebo)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • +2 more
  • Tucson, Arizona
  • +81 more
Jan 3, 2023

Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)

Recruiting
  • Lung Cancer
  • Small-cell Lung Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Nov 9, 2022

Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Carboplatin)

Terminated
Has Results
  • Small Cell Lung Cancer
  • Beverly Hills, California
  • +44 more
Apr 8, 2022

Triple Negative Breast Cancer Trial in United States (Trilaciclib, Sacituzumab Govitecan-hziy)

Recruiting
  • Triple Negative Breast Cancer
  • Chandler, Arizona
  • +21 more
Oct 25, 2022

Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)

Terminated
Has Results
  • Triple-Negative Breast Neoplasms
  • +3 more
  • Tucson, Arizona
  • +53 more
Feb 24, 2022

Idiopathic Pulmonary Fibrosis Trial in Beijing (Jaktinib DiHCl Monohydrate 50mg BID and Mimic tablets of jakitinib HCl 75mg BID

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tablets of jakitinib hydrochloride 75mg BID and Acetylcysteine Effervescent Tablets
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 29, 2021

Immune System Diseases Trial in Lugo (10 HEP/mL Betula verrucosa allergen extract, 25 HEP/mL Betula verrucosa allergen extract,

Completed
Has Results
  • Immune System Diseases
  • 10 HEP/mL Betula verrucosa allergen extract
  • +3 more
  • Lugo, Galicia, Spain
    Hospital Lucus Augusti
May 4, 2022

Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Histamine Dihydrochloride (HDC)
  • Interleukin-2 (IL-2)
  • (no location specified)
Mar 31, 2023

Myelosuppression Adult, Chemotherapeutic Toxicity, Small Cell Lung Cancer Trial (Trilaciclib)

Approved for marketing
  • Myelosuppression Adult
  • +2 more
  • (no location specified)
Mar 17, 2021

Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer Trial in United States (efatutazone, paclitaxel)

Active, not recruiting
Has Results
  • Anaplastic Thyroid Cancer
  • Recurrent Thyroid Cancer
  • Anchorage, Alaska
  • +252 more
Aug 16, 2021

Liposarcoma Trial in United States (efatutazone)

Active, not recruiting
Has Results
  • Liposarcoma
  • Little Rock, Arkansas
  • +126 more
Aug 16, 2021

Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Topotecan)

Terminated
Has Results
  • Small Cell Lung Cancer
  • Hot Springs, Arkansas
  • +49 more
May 12, 2022

Endothelial Dysfunction Trial in Hackensack (Sapropterin DiHCl, Sapropterin DiHCl and Vitamin C)

Completed
Has Results
  • Endothelial Dysfunction
  • Sapropterin Dihydrochloride
  • Sapropterin Dihydrochloride and Vitamin C
  • Hackensack, New Jersey
    (unnamed)
Apr 22, 2021

Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

Active, not recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Haikou, Hainan, China
    Hainan General Hospital
Jun 13, 2022

Preoperative Skin Preparation Trial in Butte (Chlorhexidine gluconate,

Completed
Has Results
  • Preoperative Skin Preparation
  • Chlorhexidine gluconate
  • +2 more
  • Butte, Montana
    BioScience Laboratories
Jul 12, 2021